Form 4: BioXcel Therapeutics Executive VP Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Executive Vice President of BioXcel Therapeutics, Vincent O'Neill, reports the sale of common stock and vesting of restricted stock units according to a pre-arranged trading plan.
Summary
- Vincent O'Neill, Executive Vice President of BioXcel Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On September 14, 2024, 521 Restricted Stock Units (RSUs) vested, converting into common stock.
- On September 16, 2024, O'Neill sold 138 shares of common stock at a price of $0.6908 per share.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 15, 2023.
- Following these transactions, O'Neill directly owns 3,907 shares of common stock and 3,127 RSUs.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| March 14, 2022 | Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |
| December 15, 2023 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| September 14, 2024 | 521 Restricted Stock Units vested. |
| September 16, 2024 | 138 shares of common stock were sold at $0.6908 per share. |
| September 17, 2024 | Date of the Form 4 filing. |
Keywords
Form 4, BioXcel Therapeutics, BTAI, Vincent O'Neill, Restricted Stock Units, Rule 10b5-1, Executive Vice President, Beneficial Ownership, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.